Z. Motovska

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

E. Vicaut, G. Rioufol, G. Lemesle, 2020, The Lancet.

P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis.

G. Montalescot, P. Guedeney, J. Silvain, 2023, The Canadian journal of cardiology.

Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome.

M. Kerneis, P. Guedeney, J. Silvain, 2024, JACC. Cardiovascular interventions.

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.